Scarica l'app Stockscreener
2.47
2.92%
0.07
Dopo l'orario di chiusura:
2.47
Precedente Chiudi:
$2.40
Aprire:
$2.4
Volume 24 ore:
25,117
Relative Volume:
0.73
Capitalizzazione di mercato:
$8.24M
Reddito:
$556.00K
Utile/perdita netta:
$-5.28M
Rapporto P/E:
-1.1542
EPS:
-2.14
Flusso di cassa netto:
$-6.23M
1 W Prestazione:
+3.35%
1M Prestazione:
-32.14%
6M Prestazione:
-18.48%
1 anno Prestazione:
-20.32%
Intervallo 1D:
$2.37
$2.56
Intervallo di 1 settimana:
$2.10
$2.56
Portata 52W:
$1.27
$9.4699
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Nome
Cyclerion Therapeutics Inc
Settore
Industria
Telefono
617-621-7722
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Confronta CYCN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
2.47 | 8.55M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-20 | Iniziato | Truist | Buy |
| 2021-09-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Iniziato | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie
How to forecast Cyclerion Therapeutics Inc. trends using time seriesJuly 2025 Rallies & Short-Term High Return Strategies - Newser
Will Cyclerion Therapeutics Inc. outperform the marketMarket Activity Recap & Free Daily Entry Point Trade Alerts - Newser
How to build a dashboard for Cyclerion Therapeutics Inc. stock2025 EndofYear Setup & Trade Opportunity Analysis Reports - Newser
Heatmap analysis for Cyclerion Therapeutics Inc. and competitorsFree Low Risk Equity Screener With Results - Newser
Using portfolio simulators with Cyclerion Therapeutics Inc. includedFree High Conviction Intraday Stock Signals - Newser
Institutional scanner results for Cyclerion Therapeutics Inc.Free Short Term Trading Opportunity Watch - Newser
Does Cyclerion Therapeutics Inc. show high probability of reboundPrice Spike Prediction for Active Traders - Newser
Will Cyclerion Therapeutics Inc. rebound enough to break evenFree Stock Screener With Smart Filters - Newser
Earnings visualization tools for Galectin Therapeutics Inc.Free Capital Growth With Controlled Risk Picks - Newser
Can machine learning forecast Cyclerion Therapeutics Inc. recoveryYearly Trend Summary and Opportunity Breakdown - Newser
Quantitative breakdown of Cyclerion Therapeutics Inc. recent moveFree Chart Driven High Reward Trading Setup - Newser
How Cyclerion Therapeutics Inc. stock performs during market volatilityFree Triple Digit Return Stock Predictions - Newser
Using data tools to time your Cyclerion Therapeutics Inc. exitEntry Zone Forecast for Momentum Trading - Newser
Cyclerion Therapeutics Inc. stock chart pattern explainedChart Driven Opportunity Scanner with Alerts - Newser
Is TWO.PRA trending in predictive chart modelsSecure Entry Point Finder with Analysis - Newser
Is Cyclerion Therapeutics Inc. showing signs of accumulationStock Entry Point Planner with Volume Spike - Newser
Cyclerion Therapeutics, Inc. SEC 10-Q Report - TradingView
Vascular Dementia Market to Reach New Heights in Growth by 2034, - openPR.com
What are analysts’ price targets for Cyclerion Therapeutics Inc. in the next 12 monthsInvest confidently with professional market insights - Jammu Links News
What catalysts could drive Cyclerion Therapeutics Inc. stock higher in 2025Build wealth steadily with proven stock picks - Jammu Links News
What are Cyclerion Therapeutics Inc. company’s key revenue driversGet timely alerts on top market movers - Jammu Links News
Is Cyclerion Therapeutics Inc. stock overvalued or undervaluedInvest confidently with proven investment plans - Jammu Links News
What are the technical indicators suggesting about Cyclerion Therapeutics Inc.Get exclusive market analysis for investors - Jammu Links News
How many analysts rate Cyclerion Therapeutics Inc. as a “Buy”High-octane gains - Jammu Links News
How does Cyclerion Therapeutics Inc. generate profit in a changing economyUnlock powerful stock screening tools - Jammu Links News
Why is Cyclerion Therapeutics Inc. stock attracting strong analyst attentionGet ahead with breakthrough trading ideas - Jammu Links News
Cyclerion Therapeutics Inc. Stock Analysis and ForecastExceptional ROI - Jammu Links News
What analysts say about Cyclerion Therapeutics Inc. stockAchieve rapid growth with smart investments - Jammu Links News
Cyclerion Therapeutics Inc Azioni (CYCN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):